Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GM.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GM.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GM.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.13.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.2.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.2.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.14.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used